Cas 2738-39-8,17-Hydroxy-6α,16α-dimethylpregn-4-ene-3,20-dione

2738-39-8

Post Buying Request

Basic information

Product Name: 17-Hydroxy-6α,16α-dimethylpregn-4-ene-3,20-dione
Synonyms: 17-Hydroxy-6α,16α-dimethylpregn-4-ene-3,20-dione;17-Hydroxy-6α,16α-dimethylprogesterone
CAS NO:2738-39-8
Molecular Formula: C23H34O3
Molecular Weight: 358.51426
EINECS: N/A
Product Categories: N/A
Mol File: 2738-39-8.mol

Chemical Properties

Melting Point: 203-204 °C(Solv: ethyl acetate (141-78-6); ethyl ether (60-29-7))
Boiling Point: 493.6±45.0 °C(Predicted)
Flash Point: N/A
Appearance: /
Density: 1.12±0.1 g/cm3(Predicted)
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
PKA: 13.05±0.70(Predicted)
CAS DataBase Reference: 17-Hydroxy-6α,16α-dimethylpregn-4-ene-3,20-dione(CAS DataBase Reference)
NIST Chemistry Reference: 17-Hydroxy-6α,16α-dimethylpregn-4-ene-3,20-dione(2738-39-8)
EPA Substance Registry System: 17-Hydroxy-6α,16α-dimethylpregn-4-ene-3,20-dione(2738-39-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 2738-39-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

2738-39-8 Suppliers

Recommended suppliers

2738-39-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2738-39-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,7,3 and 8 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 2738-39:
(6*2)+(5*7)+(4*3)+(3*8)+(2*3)+(1*9)=98
98 % 10 = 8
So 2738-39-8 is a valid CAS Registry Number.

2738-39-8Upstream product

2738-39-8Downstream Products

2738-39-8Relevant academic research and scientific papers

Novel 17-esters of 17α-hydroxy gestogens, compositions containing such compounds, processes for their preparation and methods of treatment therewith

-

, (2008/06/13)

This invention relates to novel 17α-esters of gestogens having an antitumour activity and to the preparation thereof. The invention is also concerned with pharmaceutical compositions containing the said compounds, and method of treatment therewith.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 2738-39-8